Received Dec 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | Y016291 | — |
Patient states he has blood tests done after receiving PNEUMOVAX 23. His provider told him that while it was consistent with an immune response, it is not necessarily providing protection, and he had low numbers on IGG test. Patient is concerned that; Patient is concerned that the vaccine did not work, although he has never had pneumonia. He suspects that he is unable to be immunized.; This spontaneous report was received from a consumer referring himself, a 72-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions included diabetes 2, high cholesterol, kidney stones, allergy to IVP iodine contrast dye, allergy to cephalosporins/azithromycin, and drug reactions/allergies to placunid. Concomitant medications included sitagliptin phosphate (JANUVIA), atorvastatin calcium (ATORVASTATIN), acetylsalicylic acid (+)Ascorbic acid (ASPIRIN), ascorbic acid (+) betacarotene(+) biotin(+) calcium (+) chlorine;chromium (+) copper (+) cyanocobalamin (+) dl-alpha tocopheryl acetate(+) folic acid (+) iodine (+) magnesium (+) manganese (+) molybdenum(+) nickel(+) nicotinamide(+) pantothenic acid(+) phosphorus(+) phytomenadione(+) potassium(+) pyridoxine hydrochloride(+) retinol(+) riboflavin(+) selenium(+) silicon(+) thiamine(+) vanadium(+) vitamin d nos(+) xantofyl(+) zinc (CENTRUM SILVER +50 ) + multivitamin; potassium citrates and alkali citrate. On 07-OCT-2025, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (lot #Y016291, has been verified to be valid, expiration date not reported but upon internal validation established as 06-DEC-2026) (route and anatomical location were not reported) as prophylaxis. The operator of device was healthcare professional. On unspecified date in 2025 (conflicting information reported as ''onset date 07-OCT-2025, also reported as after receiving vaccine''), the patient stated he had blood tests done after receiving Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23). His provider told him that while it was consistent with an immune response, it was not necessarily providing protection, and he had low numbers on IGG test (antibody test abnormal). Patient was concerned that the vaccine did not work, although he had never had pneumonia. He suspects that he was unable to be immunized (vaccination failure). He stated that he was happy to provide his bloodwork for study. At the reporting time, the outcome of the events was unknown (conflicting information reported as ''not recovered'') The event of vaccination failure was considered to be related to Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23). However, the causality for antibody test abnormal was not provided.
Allergy to antibiotic; Drug allergy; High cholesterol; Iodine contrast media allergy; Kidney stones; Type 2 diabetes mellitus
atorvastatin; aspirin; centrum silver 50+ multivitamin; JANUVIA 50 MG